Asosiy kontentga oʻtish
proceeding

THERAPEUTIC POTENTIAL OF METHYLURACIL IN ORAL MUCOSAL DISEASES: CURRENT EVIDENCE AND CLINICAL PERSPECTIVES

Sardorbek ErkinboyevDepartment of Pediatric Dentistry, Andijan State Medical Institute, Andijan, Uzbekistan
2026
Ochiq kirishGibrid

Litsenziya: cc-by

ABI

Annotatsiya

Diseases of the oral mucosa frequently present with epithelial injury, ulceration, inflammation, pain, and impaired oral intake. Despite the availability of symptomatic, anti-inflammatory, antimicrobial, and protective treatments, management of mucosal lesions remains clinically challenging, particularly when rapid restoration of epithelial integrity is required. Methyluracil (6-methyluracil; dioxomethyltetrahydropyrimidine) is a pyrimidine derivative that has historically been used as a reparative and epithelializing agent. Its proposed biological effects include stimulation of reparative processes, modulation of inflammation, and effects on nucleic-acid metabolism and oxidative processes

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar